Clinical trial
Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis
NCT06228781 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis
- Lead sponsor
- Tianjin Medical University General Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- January 1, 2029
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.